Postsynaptic Membrane Dysfunction

Image

Thymoma is the most common tumor of the anterior mediastinum and can occur at any age. Myasthenia gravis (MG) is the most common autoimmune disease associated with thymoma and accounts for 20–30% of all thymomas. Thymoma may rarely remission with or without treatment for myasthenia gravis. In cases of thymoma and myasthenia gravis diagnosed simultaneously, initiation of myasthenia gravis treatment before surgery may regress the thymoma and make surgical resection easier. In any case, clinical control of myasthenia gravis is necessary before a surgical approach to thymoma.The cholinergic neuromuscular junction is the paradigm peripheral synapse between a motor neuron nerve ending and a skeletal muscle fiber. In vertebrates, acetylcholine is released from the presynaptic site and binds to the nicotinic acetylcholine receptor at the postsynaptic membrane. A variety of pathologies among which myasthenia gravis stands out can impact on this rapid and efficient signaling mechanism, including autoimmune diseases affecting the nicotinic receptor or other synaptic proteins.

Cholesterol is an essential component of biomembranes and is particularly rich at the postsynaptic membrane, where it interacts with and modulates many properties of the nicotinic receptor. The profound changes inflicted by myasthenia gravis on the postsynaptic membrane necessarily involve cholesterol. This review analyzes some aspects of myasthenia gravis pathophysiology and associated postsynaptic membrane dysfunction, including dysregulation of cholesterol metabolism in the myocyte brought about by antibody-receptor interactions. In addition, given the extensive therapeutic use of statins as the typical cholesterol-lowering drugs, we discuss their effects on skeletal muscle and the possible implications for MG patients under chronic treatment with this type of compound.

visit for more articles at Journal of Autoimmune Disorders

Kindly submit your article at  https://www.imedpub.com/submissions/autoimmune-disorders.html 

Regards
Mishita
Jornal co-ordinator
Journal of Journal of Autoimmune Disorders